The Georgia House on March 9 adopted House Resolution 948, establishing a study committee to examine pharmacy benefit managers and consumer access to prescription medications.
Representative Ron Stevens, who presented the committee substitute on the House floor, said the panel will “reverse engineer” how employers and self-insured plans are billed and examine mail-order and 340B pharmacy arrangements. “We’re gonna see if we can find out exactly what employers are being billed versus what they’re paying on these self insurance plans,” Stevens said, and described the inquiry as aimed at understanding how PBMs’ commercial arrangements affect plan costs.
The study committee was created by a committee substitute that the House adopted without objection. On the subsequent passage vote, the clerk recorded 157 yeas and 0 nays; the resolution therefore carried the requisite constitutional majority.
Why it matters: PBMs administer prescription benefits for many employers and insurers; supporters of the study argued the committee could identify gaps between prices charged and amounts passed to plans, potential effects of mandatory mail-order rules, and whether current practices affect cost and access for patients.
What the resolution does and next steps: HR 948 directs the House to form a study committee that will hold hearings and request information from stakeholders and state agencies; no statutory changes were adopted on the floor. The resolution’s sponsor said the committee will probe PBM practices, profit flows, and whether market structures affect consumers’ access to medications. The House did not set a final reporting date on the floor during the session’s adoption.
The clerk read the resolution’s caption and committee referral before the presentation and vote; the committee substitute was agreed to on the floor and then approved by recorded vote. The study committee’s meetings, witnesses and any staff work will be public records once scheduled by the committee.